Skip to main content
Large building surrounded by trees
Archive Research Updates

Research Updates

Archived Research Updates

2018 Research Updates

2018 Research

2018 KDA Conference Research Presentations 

J. Paul Taylor, M.D., Ph.D. NIH, Transitioning to University of Pennsylvania, Philadelphia (USA). Drosophila (fruit fly) Models
 
Andrew Lieberman, M.D., Ph.D. - University of Michigan (USA). Creation of a KD Knock-in Mouse Model
 
Nicholas Di Prospero, M.D., Ph.D. National Institutes of Health, NINDS (Bethesda, MD). Kennedy's Disease Clinical Trials
 
Jean-Marc Gallo, Ph.D. King's College, London (England). Common ground between KD & other neurological diseases

Trial Shows Positive Initial Results for IGF-1. To learn more, click here

Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. To learn more, click here. 

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents. This study focuses on identifying a miRNA that directly downregulates expression of the mutant AR transgene and on designing a safe and efficient mode of delivery of the miRNA to the spinal cord and skeletal muscle of our disease mouse model. For onformation on this study, click here.  

 

Carlo Rinaldi, associate professor and clinician scientist at the University of Oxford in England, was awarded an MDA Development Grant totaling $120,000 over 3 years to study the role of androgen receptor isoforms in SBMA. The MDA just announced it is funding 34 new research projects totaling 9.9 million dollars. For more information, click here.

 

Study identifies potential drug for treatment of Kennedy's Disease. To read the Medical Press article, click here

Return To List
MENU CLOSE